Soleno Therapeutics Inc (NASDAQ: SLNO) is -0.96% lower on its value in year-to-date trading and has touched a low of $36.20 and a high of $60.92 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SLNO stock was last observed hovering at around $46.22 in the last trading session, with the day’s loss setting it -1.7%.
Currently trading at $44.52, the stock is -3.15% and -12.79% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.46 million and changing -3.68% at the moment leaves the stock -5.77% off its SMA200. SLNO registered 9.71% gain for a year compared to 6-month gain of 3.56%. The firm has a 50-day simple moving average (SMA 50) of $51.2594 and a 200-day simple moving average (SMA200) of $47.23235.
The stock witnessed a -9.42% loss in the last 1 month and extending the period to 3 months gives it a -14.34%, and is -0.96% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.78% over the week and 4.50% over the month.
Soleno Therapeutics Inc (SLNO) has around 42 employees, a market worth around $1.92B and $0.00M in sales. Distance from 52-week low is 22.98% and -26.92% from its 52-week high. The company has generated returns on investments over the last 12 months (-49.07%).
The EPS is expected to shrink by -75.36% this year
205.0 institutions hold shares in Soleno Therapeutics Inc (SLNO), with institutional investors hold 104.13% of the company’s shares. The shares outstanding are 41.04M, and float is at 32.11M with Short Float at 13.79%. Institutions hold 100.96% of the Float.
The top institutional shareholder in the company is VIVO CAPITAL, LLC with over 7.32 million shares valued at $298.53 million. The investor’s holdings represent 20.2076 of the SLNO Shares outstanding. As of 2024-06-30, the second largest holder is CARLYLE GROUP INC. with 4.07 million shares valued at $166.36 million to account for 11.2448 of the shares outstanding. The other top investors are JANUS HENDERSON GROUP PLC which holds 3.36 million shares representing 9.2765 and valued at over $137.14 million, while PERCEPTIVE ADVISORS LLC holds 8.8515 of the shares totaling 3.2 million with a market value of $130.76 million.
Soleno Therapeutics Inc (SLNO) Insider Activity
The most recent transaction is an insider sale by Yen Kristen,. SEC filings show that Yen Kristen sold 2,520 shares of the company’s common stock on Jan 02 ’25 at a price of $45.41 per share for a total of $0.11 million. Following the sale, the insider now owns 78945.0 shares.
Soleno Therapeutics Inc disclosed in a document filed with the SEC on Jan 03 ’25 that Yen Kristen sold a total of 2,340 shares of the company’s common stock. The trade occurred on Jan 03 ’25 and was made at $46.18 per share for $0.11 million. Following the transaction, the insider now directly holds 76605.0 shares of the SLNO stock.
Still, SEC filings show that on Jan 02 ’25, Mackaness James H (CHIEF FINANCIAL OFFICER) disposed off 4,083 shares at an average price of $45.41 for $0.19 million. The insider now directly holds 115,089 shares of Soleno Therapeutics Inc (SLNO).
